Cholera Toxin Up-Regulates Endoplasmic Reticulum Proteins That Correlate with Sensitivity to the Toxin

Abstract

Cholera toxin (CT) contains one A chain and five B chains. The A chain is an enzyme that covalently modifies a trimeric G protein in the cytoplasm, resulting in the overproduction of cAMP. The B chain binds the glycosphingolipid G_M1, the cell surface receptor for CT, which initiates receptor-mediated endocytosis of the toxin. After endocytosis, CT enters the endoplasmic reticulum (ER) via retrograde vesicular traffic where the A chain retro-translocates through the ER membrane to reach the cytoplasm. The retro-translocation mechanism is poorly understood, but may involve proteins of the ER stress response, including the ER associated degradation (ERAD) pathway. We report here that treating cells with CT or CTB quickly up-regulates the levels of BiP, Derlin-1, and Derlin-2, known participants in the ER stress response and ERAD. CT did not induce calnexin, another known responder to ER stress, indicating that the CT-mediated induction of ER proteins is selective in this time frame. These data suggest that CT may promote retro-translocation of the A chain to the cytoplasm by rapidly up-regulating a set of ER proteins involved in the retro-translocation process. In support of this idea, a variety of conditions that induced BiP, Derlin-1, and Derlin-2 sensitized cells to CT and conditions that inhibited their induction de-sensitized cells to CT. Moreover, specifically suppressing Derlin-1 with siRNA protected cells from CT. In addition, Derlin-1 co-immunoprecipitated with CTA or CTB from CT-treated cells using anti-CTA or anti-CTB antibodies. Altogether, the results are consistent with the hypothesis that the B chain of CT up-regulates ER proteins that may assist in the retro-translocation of the A chain across the ER membrane.

Get full access to this article

View all access options for this article.

References

Chen A, Hu T, Mikoryak C, Draper RK. Retrograde transport of protein toxins under conditions of COPI dysfunction. Biochim Biophys Acta 1589:124–139, 2002.

De Haan L, Hirst TR. Cholera toxin: A paradigm for multi-functional engagement of cellular mechanisms (Review). Mol Membr Biol 21:77–92, 2004.

Spooner RA, Smith DC, Easton AJ, Roberts LM, Lord JM. Retrograde transport pathways utilised by viruses and protein toxins. Virol J 3:26, 2006.

Schmitz A, Herrgen H, Winkeler A, Herzog V. Cholera toxin is exported from microsomes by the Sec61p complex. J Cell Biol 148: 1203–1212, 2000.

Tsai B, Rodighiero C, Lencer WI, Rapoport TA. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 104:937–948, 2001.

Lord JM, Roberts LM. Retrograde transport: going against the flow. Curr Biol 8:R56–58, 1998.

Lord JM, Deeks E, Marsden CJ, Moore K, Pateman C, Smith DC, Spooner RA, Watson P, Roberts LM. Retrograde transport of toxins across the endoplasmic reticulum membrane. Biochem Soc Trans 31: 1260–1262, 2003.

Hazes B, Read RJ. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochem 36:11051–11054, 1997.

Winkeler A, Godderz D, Herzog V, Schmitz A. BiP-dependent export of cholera toxin from endoplasmic reticulum-derived microsomes. FEBS Lett 554:439–442, 2003.

10.

Orlandi PA. Protein-disulfide isomerase-mediated reduction of the A subunit of cholera toxin in a human intestinal cell line. J Biol Chem 272:4591–4599, 1997.

11.

Tsai B, Rapoport TA. Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1. J Cell Biol 159:207–216, 2002.

12.

Jarosch E, Lenk U, Sommer T. Endoplasmic reticulum-associated protein degradation. Int Rev Cytol 223:39–81, 2003.

13.

AbuJarour R, Dalal S, Hansen M, Draper RK. p97 is in a complex with cholera toxin and influences the transport of cholera toxin and related toxins to the cytoplasm. J Biol Chem 280:15865–15871, 2005.

14.

Kothe M, Ye Y, Wagner JS, DeLuca H, Kern E, Rapoport TA, Lencer WI. Role of p97 AAA-ATPase in the retro-translocation of the cholera toxin A1 chain, a non-ubiquitinated substrate. J Biol Chem 280:28127–28132, 2005.

15.

Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 74:739–789, 2005.

16.

Hardy SJ, Holmgren J, Johansson S, Sanchez J, Hirst TR. Coordinated assembly of multisubunit proteins: Oligomerization of bacterial enterotoxins in vivo and in vitro. Proc Natl Acad Sci U S A 85:7109–7113, 1988.

17.

Majoul IV, Bastiaens PIH, Söling H-D. Transport of an external Lys-Asp-Glu-Leu (KDEL) protein from the plasma membrane to the endoplasmic reticulum: studies with cholera toxin in Vero cells. J Cell Biol 133:777–789, 1996.

18.

Majoul I, Sohn K, Wieland FT, Pepperkok R, Pizza M, Hillemann J, Soling HD. KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A subunit from the Golgi involves COPI, p23, and the COOH terminus of Erd2p. J Cell Biol 143:601–612, 1998.

19.

Bastiaens PI, Majoul IV, Verveer PJ, Soling HD, Jovin TM. Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J 15:4246–4253, 1996.

20.

Hu T, Kao C-Y, Hudson RT, Chen A, Draper RK. Inhibition of secretion by 1,3-cyclohexanebis(methylamine), a dibasic compound that interferes with coatomer function. Mol Biol Cell 10:921–933, 1999.

21.

Lilley BN, Ploegh HL. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429:834–840, 2004.

22.

Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429:841–847, 2004.

23.

Bernales S, Papa FR, Walter P. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 22:487–508, 2006.

24.

Gulow K, Bienert D, Haas IG. BiP is feed-back regulated by control of protein translation efficiency. J Cell Sci 115:2443–2452, 2002.

25.

Wong WL, Brostrom MA, Kuznetsov G, Gmitter-Yellen D, Brostrom CO. Inhibition of protein synthesis and early protein processing by thapsigargin in cultured cells. Biochem J 289 (Pt 1):71–79, 1993.

26.

Oda Y, Okada T, Yoshida H, Kaufman RJ, Nagata K, Mori K. Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J Cell Biol 172:383–393, 2006.

27.

Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4:181–191, 2003.

28.

Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L, Jobling MG, Rapoport T, Holmes RK, Lencer WI. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulum. Mol Biol Cell 14:4783–4793, 2003.

29.

De Wolf MJ, Dams E, Dierick WS. Interaction of a cholera toxin derivative containing a reduced number of receptor binding sites with intact cells in culture. Biochim Biophys Acta 1223:296–305, 1994.

30.

Fernandez J, Yaman I, Sarnow P, Snider MD, Hatzoglou M. Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2alpha. J Biol Chem 277:19198–19205, 2002.

31.

Sarnow P. Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited. Proc Natl Acad Sci U S A 86:5795–5799, 1989.

32.

Macejak DG, Sarnow P. Internal initiation of translation mediated by the 5′ leader of a cellular mRNA. Nature 353:90–94, 1991.

33.

Hollien J, Weissman JS. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313:104–107, 2006.

34.

Gouy H, Deterre P, Debre P, Bismuth G. Cell calcium signaling via GM1 cell surface gangliosides in the human Jurkat T cell line. J Immunol 152:3271–3281, 1994.

35.

Tessitore A, del PMM, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler DA, Hendershot LM, d’Azzo A. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell 15:753–766, 2004.

36.

Sandvig K, Garred O, van Deurs B. Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum. Proc Natl Acad Sci U S A 93:12339–12343, 1996.

37.

Ikari A, Sakai H, Takeguchi N. ATP, thapsigargin and cAMP increase Ca2+ in rat hepatocytes by activating three different Ca2+ influx pathways. Jpn J Physiol 47:235–239, 1997.

38.

Hagmann J, Fishman PH. Inhibitors of protein synthesis block action of cholera toxin. Biochem Biophys Res Commun 98:677–684, 1981.

39.

Ye Y, Shibata Y, Kikkert M, van Voorden S, Wiertz E, Rapoport TA. Inaugural Article: Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 102:14132–14138, 2005.

40.

Lilley BN, Ploegh HL. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 102: 14296–14301, 2005.

41.

Johannes L, Tenza D, Antony C, Goud B. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J Biol Chem 272:19554–19561, 1997.

42.

Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510–512, 1992.

43.

Falguieres T, Johannes L. Shiga toxin B-subunit binds to the chaperone BiP and the nucleolar protein B23. Biol Cell 98:125–134, 2006.

44.

Slominska-Wojewodzka M, Gregers TF, Walchli S, Sandvig K. EDEM is involved in retrotranslocation of ricin from the endoplasmic reticulum to the cytosol. Mol Biol Cell 17:1664–1675, 2006.

45.

Plant A, Williams NA. Modulation of the immune response by the cholera-like enterotoxins. Curr Top Med Chem 4:509–519, 2004.

46.

Francis ML, Ryan J, Jobling MG, Holmes RK, Moss J, Mond JJ. Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J Immunol 148:1999–2005, 1992.

47.

Elson CO, Holland SP, Dertzbaugh MT, Cuff CF, Anderson AO. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J Immunol 154:1032–1040, 1995.

48.

Rouquette-Jazdanian AK, Foussat A, Lamy L, Pelassy C, Lagadec P, Breittmayer JP, Aussel C. Cholera toxin B-subunit prevents activation and proliferation of human CD4+ T cells by activation of a neutral sphingomyelinase in lipid rafts. J Immunol 175:5637–5648, 2005.

49.

Finkelstein RA, LoSpalluto JJ. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid. J Exp Med 130:185–202, 1969.

50.

Hirst TR, Sanchez J, Kaper JB, Hardy SJ, Holmgren J. Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli. Proc Natl Acad Sci U S A 81:7752–7756, 1984.